However, contrary to solid malignancy behavior, in MM higher CD24 expression is correlated with greater survival rates and overall better prognosis, as CD24-positive plasma cells present less tumorigenic behavior than CD24-negative plasma cells. Here, CD24 is linked to Miyoshi myopathy.